
Coherence is developing the world's first closed loop neuromodulation system to treat Glioblastoma (a deadly brain cancer). Coherence's device is implanted in the brain during routine brain tumor removal surgery. The device then monitors the tumor removal site and uses electrical stimulation to kill any tumor regrowth.
Under the radar for now - more info soon.
2025
XEIA invests
2026
Coherence raises $10M seed round led by Topology
Coherence raises $10M seed round led by Topology
The latest from
Coherence
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance